IL230682A0 - Stable polymorphic forms of a compound as hypoxia mimics and their uses - Google Patents

Stable polymorphic forms of a compound as hypoxia mimics and their uses

Info

Publication number
IL230682A0
IL230682A0 IL230682A IL23068214A IL230682A0 IL 230682 A0 IL230682 A0 IL 230682A0 IL 230682 A IL230682 A IL 230682A IL 23068214 A IL23068214 A IL 23068214A IL 230682 A0 IL230682 A0 IL 230682A0
Authority
IL
Israel
Prior art keywords
compound
polymorphic forms
stable polymorphic
hypoxia mimetics
mimetics
Prior art date
Application number
IL230682A
Other languages
English (en)
Hebrew (he)
Original Assignee
Beijing Betta Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Betta Pharmaceuticals Co Ltd filed Critical Beijing Betta Pharmaceuticals Co Ltd
Publication of IL230682A0 publication Critical patent/IL230682A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL230682A 2011-07-29 2014-01-28 Stable polymorphic forms of a compound as hypoxia mimics and their uses IL230682A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201110215826 2011-07-29
CN201110219607 2011-08-02
CN201110232754 2011-08-15
PCT/CN2012/079361 WO2013017063A1 (en) 2011-07-29 2012-07-30 Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof

Publications (1)

Publication Number Publication Date
IL230682A0 true IL230682A0 (en) 2014-03-31

Family

ID=47628644

Family Applications (1)

Application Number Title Priority Date Filing Date
IL230682A IL230682A0 (en) 2011-07-29 2014-01-28 Stable polymorphic forms of a compound as hypoxia mimics and their uses

Country Status (10)

Country Link
US (1) US9238637B2 (enExample)
EP (1) EP2736892A4 (enExample)
JP (1) JP2014523917A (enExample)
KR (1) KR20140076549A (enExample)
CN (1) CN103946218B (enExample)
AU (1) AU2012289563A1 (enExample)
CA (1) CA2843240A1 (enExample)
IL (1) IL230682A0 (enExample)
WO (1) WO2013017063A1 (enExample)
ZA (1) ZA201401448B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2959688C (en) 2014-09-02 2024-02-27 Sunshine Lake Pharma Co., Ltd. Quinolone compounds and their use to treat diseases related to hypoxia inducible factor and/or erythropoietin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0715636A2 (pt) * 2006-08-29 2013-07-02 Teva Pharma composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo
US8324405B2 (en) * 2008-02-05 2012-12-04 Fibrogen, Inc. Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors
IN2012DN00549A (enExample) * 2009-07-15 2015-06-12 Zhejiang Beta Pharma Inc

Also Published As

Publication number Publication date
EP2736892A4 (en) 2015-03-18
WO2013017063A1 (en) 2013-02-07
JP2014523917A (ja) 2014-09-18
CN103946218A (zh) 2014-07-23
KR20140076549A (ko) 2014-06-20
AU2012289563A2 (en) 2014-07-03
ZA201401448B (en) 2015-04-29
US20140343137A1 (en) 2014-11-20
CN103946218B (zh) 2016-03-09
US9238637B2 (en) 2016-01-19
AU2012289563A1 (en) 2014-03-13
EP2736892A1 (en) 2014-06-04
CA2843240A1 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
ZA201400330B (en) Novel composition
ZA201308399B (en) Improved composition
ZA201404065B (en) Tricyclic compounds, compositions comprising them and uses thereof
PT2768864T (pt) Composições com concentrações aumentadas de carboximetilcelulose
GB201120616D0 (en) Composition
GB201122305D0 (en) Novel compound
GB201119601D0 (en) Composition
LT2734186T (lt) Kompozicija
GB201117037D0 (en) Composition
GB201121258D0 (en) Composition
GB201115211D0 (en) Composition
GB201108912D0 (en) Composition
GB201103964D0 (en) Composition
ZA201401448B (en) Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof
IL222903A0 (en) Composition of small molecule therapeutices
GB201322023D0 (en) Composition
EP2711011A4 (en) COMPOSITION CONTAINING PANAXADIOL
GB201204957D0 (en) Composition
GB201112987D0 (en) Novel compound
GB201121300D0 (en) Novel composition
GB201216884D0 (en) Composition
GB201118701D0 (en) Composition
IL232620A0 (en) Tricyclic compounds, preparations including them and their use
GB201107756D0 (en) Novel composition
PL395354A1 (pl) Kompozycja fungicydowa